Results 31 to 40 of about 524,632 (318)

Letter from Vladimir Georgiev to No Recipient, January 01, 1953

open access: yes, 1953
Georgiev wishes the recipient a Happy New Year ...
Georgiev, Vladimir
core   +1 more source

An analysis of the stress levels, influencing factors and countermeasures of kidney transplant recipients in a certain hospital

open access: yesFrontiers in Public Health
BackgroundKidney transplantation remains the most effective therapeutic intervention, significantly enhancing long-term survival rates and overall well-being.
Jingyi Jiang   +6 more
doaj   +1 more source

Recipient Characteristics.

open access: yes, 2021
Recipient Characteristics.
Melissa Baker (10346326)   +11 more
core   +1 more source

The Role of Emerging Donors in the Transformation of Traditional Donor Recipient Relationships: The Case of China in Myanmar

open access: yes, 2019
The aid recipients have suffered from bargaining power inequality under traditional donor-recipient relationship. This article explores how an aid recipient could overcome their position through leveraging the role of emerging donors, or non-traditional ...
Shimomura, Yasutami, 1500
core   +1 more source

Aplicação da ultrassonografia colorida doppler em programas de transferência de embriões equinos Potential use of doppler ultrasound in equine embryo transfer programs

open access: yesCiência Rural, 2011
Os programas comerciais de transferência de embriões em éguas existem por mais de três décadas e são hoje uma das biotécnias mais utilizadas na reprodução assistida de equinos.
Jair Camargo Ferreira   +1 more
doaj   +1 more source

Cancer in the Transplant Recipient [PDF]

open access: yesCold Spring Harbor Perspectives in Medicine, 2013
Malignancy has become one of the three major causes of death after transplantation in the past decade and is thus increasingly important in all organ transplant programs. Death from cardiovascular disease and infection are both decreasing in frequency from a combination of screening, prophylaxis, aggressive risk factor management, and interventional ...
Jeremy R, Chapman   +2 more
openaire   +2 more sources

Donor Family and Recipient Anonymity: Time for Change

open access: yes, 2019
Purpose Policies and procedures exist in many jurisdictions regarding ‘anonymity’. These prohibit communication between transplant recipients and donor families.
Jan, E.   +11 more
core   +1 more source

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele   +19 more
wiley   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Health‐Related Quality of Life and Symptom Severity Among Patients With PIK3CA‐Related Overgrowth Spectrum: A Mixed‐Methods Study to Understand Real‐World Experience With Alpelisib Treatment

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy